Leukemia Immune Profiles Predict Drug Resistance and Benefits of Immunotherapy (3 of 5) (IMAGE)

American Association for the Advancement of Science (AAAS)

Leukemia Immune Profiles Predict Drug Resistance and Benefits of Immunotherapy (3 of 5)

Caption

Evidence of T-cell clustering around CD123-expressing acute myeloid leukemia in a patient who achieved complete response after flotetuzumab immunotherapy. This material relates to a paper that appeared in the Jun. 3, 2020, issue of <i>Science Translational Medicine</i>, published by AAAS. The paper, by J. Vadakekolathu at Nottingham Trent University in Nottingham, UK; and colleagues was titled, "Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia."

Credit

[Credit: Sergio Rutella, Nottingham Trent University]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.